Skip to main content
AQST filings

Corporate insider profile

Julie Krop Filing Activity

Latest reported as Director of Aquestive Therapeutics, Inc. (AQST).

Purchase filings
0
Reported companies
1
Net open-market value
-$125,392.50
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026Aquestive Therapeutics, Inc. (AQST)DirectorSale25,000$5.02$125,393